Morris Arlene
SEC Form 4 insider trading activity
Morris Arlene has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 31, 2026.
On the most recent filing, Morris Arlene is listed as Director at Cogent Biosciences, Inc. Inside the rolling window, Morris Arlene reported no open-market purchases and 1 open-market sale totaling $1.7M in COGT.
Companies traded
Other insiders at COGT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Morris Arlene made?
Morris Arlene has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Morris Arlene trade?
Morris Arlene has filed SEC Form 4 disclosures for 1 company, including COGT.
When was Morris Arlene's most recent SEC Form 4 filing?
Morris Arlene's most recent SEC Form 4 filing on Tracefour is dated Aug 31, 2026.
What is Morris Arlene's total buy and sell value in the current window?
Inside the rolling retention window, Morris Arlene bought $0 and sold $1.7M based on SEC Form 4 filings.
What was Morris Arlene's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 45,510 COGT shares on 2026-08-27, worth $1.7M, per SEC Form 4 filings.